Postgraduate Course: Vaccine Development and Clinical Testing (PGBI11063)
Course Outline
| School | School of Biological Sciences |
College | College of Science and Engineering |
| Course type | Standard |
Availability | Available to all students |
| Credit level (Normal year taken) | SCQF Level 11 (Postgraduate) |
Credits | 10 |
| Home subject area | Postgraduate |
Other subject area | None |
| Course website |
None |
Taught in Gaelic? | No |
| Course description | An expanded Biotechnology 4 module on vaccine development (BITE10012) will be augmented further into a 10 credit module available as an MSc course option. It will cover the existing vaccination production and deployment operations as well as the efforts to develop new vaccines against such human diseases as malaria, HIV and dengue fever and animal diseases such as brucellosis and trypanosomiasis. The regulatory framework governing pre-clinical and clinical testing of vaccines will also be taught.
|
Entry Requirements (not applicable to Visiting Students)
| Pre-requisites |
|
Co-requisites | |
| Prohibited Combinations | |
Other requirements | None |
| Additional Costs | None |
Information for Visiting Students
| Pre-requisites | None |
| Displayed in Visiting Students Prospectus? | No |
Course Delivery Information
|
| Delivery period: 2011/12 Semester 2, Available to all students (SV1)
|
WebCT enabled: Yes |
Quota: None |
| Location |
Activity |
Description |
Weeks |
Monday |
Tuesday |
Wednesday |
Thursday |
Friday |
| King's Buildings | Lecture | | 1-11 | | 09:00 - 12:00 | | | | | King's Buildings | Lecture | | 1-11 | | | | 09:00 - 12:00 | |
| First Class |
Week 18, Tuesday, 09:00 - 12:00, Zone: King's Buildings. Darwin 315 |
| No Exam Information |
Summary of Intended Learning Outcomes
At the end of the course a student should be able to;
&·Demonstrate an advanced understanding of the existing global vaccination effort, vaccine-based epidemic control and disease eradication initiatives.
&·Demonstrate an advanced understanding of the global vaccine industry and the regulatory framework it operates in.
&·Demonstrate an understanding of where research on infections currently without vaccines stands and of difficulties in trying to develop vaccines against highly variable infectious agents such as malaria and HIV.
&·Demonstrate an understanding of Good Clinical Practica (GCP) and Good Laboratory Practic (GLP) governed vaccine clinical testing.
|
Assessment Information
Course essay (100%), 2500 words max.
As part of this course, tutorial support (3-4 one hour sessions) on how to structure and write scientific essays will be given, including in-class writing exercises tailored to this course. |
Special Arrangements
| None |
Additional Information
| Academic description |
Not entered |
| Syllabus |
Not entered |
| Transferable skills |
Not entered |
| Reading list |
Not entered |
| Study Abroad |
Not entered |
| Study Pattern |
Not entered |
| Keywords | BIOTECH Vacc Devp |
Contacts
| Course organiser | Dr David Arnot
Tel: (0131 6)50 5503
Email: D.E.Arnot@ed.ac.uk |
Course secretary | Miss Sarah Anderson
Tel: (0131 6)50 8643
Email: Sarah.H.Anderson@ed.ac.uk |
|
© Copyright 2011 The University of Edinburgh - 16 January 2012 6:31 am
|
University Homepage